Successful drugs require a delicate balance of many properties, such as potency, ADME and toxicity, to meet a project’s objective.
To make decisions on compound progression and assay selection, data must be assessed against project specific criteria.
The data on which we base our decisions often come from different sources and can vary in quality.
- How can we use this data to make confident decisions?
- How can we be sure that the criteria we’re using are the most appropriate?
Join Optibrium’s CEO Matt Segall to explore the art of multi-parameter optimisation in this webinar.
For more resources on multi-parameter optimisation, see:
Our review article: optibrium.com/...
MPO Explorer module: optibrium.com/...
Tutorial video: optibrium.com/...
Негізгі бет Finding balance in drug discovery through multi-parameter optimisation
Пікірлер